SCHEMBL5082730

SCHEMBL5082730

Cc1c(CN(C)C(=O)C=Cc2cnc3c(c2)CN(CC(=O)N2CCN(C)CC2)CC(=O)N3)sc2ccccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5082722 1.00
Hydrochloric Acid SCHEMBL1253066 0.99
Hydrochloric Acid SCHEMBL1253069 0.99
SCHEMBL5078276 0.91
SCHEMBL5078282 0.91
Hydrochloric Acid SCHEMBL1253021 0.90
Hydrochloric Acid SCHEMBL1253020 0.90
SCHEMBL5082760 0.90
SCHEMBL5082755 0.90
SCHEMBL1253339 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575951-B1 HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY DEBIOPHARM INT SA (CH) 2014-06-25 EP claimed
EP-1608377-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF FAB I AND FURTHER ANTIBIOTICS AFFINIUM PHARM INC (CA) 2008-10-01 EP claimed